1. Home
  2. AZTR vs PLRZ Comparison

AZTR vs PLRZ Comparison

Compare AZTR & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • PLRZ
  • Stock Information
  • Founded
  • AZTR 2014
  • PLRZ 2005
  • Country
  • AZTR United States
  • PLRZ Israel
  • Employees
  • AZTR N/A
  • PLRZ N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • PLRZ
  • Sector
  • AZTR Health Care
  • PLRZ
  • Exchange
  • AZTR Nasdaq
  • PLRZ NYSE
  • Market Cap
  • AZTR 3.6M
  • PLRZ 3.4M
  • IPO Year
  • AZTR 2023
  • PLRZ 2024
  • Fundamental
  • Price
  • AZTR $0.41
  • PLRZ $2.83
  • Analyst Decision
  • AZTR
  • PLRZ
  • Analyst Count
  • AZTR 0
  • PLRZ 0
  • Target Price
  • AZTR N/A
  • PLRZ N/A
  • AVG Volume (30 Days)
  • AZTR 121.9K
  • PLRZ 487.1K
  • Earning Date
  • AZTR 11-12-2024
  • PLRZ 12-24-2024
  • Dividend Yield
  • AZTR N/A
  • PLRZ N/A
  • EPS Growth
  • AZTR N/A
  • PLRZ N/A
  • EPS
  • AZTR N/A
  • PLRZ N/A
  • Revenue
  • AZTR $97,500.00
  • PLRZ N/A
  • Revenue This Year
  • AZTR $494.75
  • PLRZ N/A
  • Revenue Next Year
  • AZTR N/A
  • PLRZ N/A
  • P/E Ratio
  • AZTR N/A
  • PLRZ N/A
  • Revenue Growth
  • AZTR N/A
  • PLRZ N/A
  • 52 Week Low
  • AZTR $0.40
  • PLRZ $0.77
  • 52 Week High
  • AZTR $68.40
  • PLRZ $1.97
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 37.74
  • PLRZ N/A
  • Support Level
  • AZTR $0.40
  • PLRZ N/A
  • Resistance Level
  • AZTR $0.51
  • PLRZ N/A
  • Average True Range (ATR)
  • AZTR 0.03
  • PLRZ 0.00
  • MACD
  • AZTR -0.00
  • PLRZ 0.00
  • Stochastic Oscillator
  • AZTR 29.84
  • PLRZ 0.00

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About PLRZ POLYRIZON LTD

Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.

Share on Social Networks: